Carle Health System Regional Seminar on Diabetes 2025

+ Include: 1 videos + 1 pdf, size: 2.02 GB

+ Target Audience: endocrinologists and primary care physicians

+ Information:

1. Overview

The Carle Health System Regional Seminar on Diabetes is a professional educational program focused on advanced cardiometabolic care and diabetes management. Taking place on October 17, 2025, this seminar provides critical updates on continuous glucose monitoring, targeted pharmacotherapies like SGLT2 inhibitors and GLP-1 agonists, and the management of associated conditions such as steatotic liver disease and cardiovascular disease.

2. Learning Objectives

• Evaluate the cardiovascular and renal benefits of SGLT2 inhibitors and GLP-1 agonists in patients with diabetes.

• Implement continuous glucose monitoring technologies to optimize comprehensive cardiometabolic and kidney care.

• Formulate management strategies for metabolic dysfunction-associated steatotic liver disease (MASLD) in diabetic patients.

• Incorporate updated insulin therapies and cardiac rehabilitation protocols into holistic patient treatment plans.

3. Target Audience

Best for endocrinologists and primary care physicians who want key updates on diabetes technology, targeted therapies, and cardiometabolic care.

4. Topics

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

• Friday, October 17, 2025.mp4 Full Live

*Detail:

• 8:00 a.m. – 8:15 a.m. Opening Remarks Kingsley Onyemere, MD, MPH, FACP Endocrinology Carle Health
• 8:15 a.m. – 9:00 a.m. Cardiovascular Benefits of SGLT2-Inhibitors and GLP-1 Agonists Karen Wiarda, DO Carle Heart and Vascular Institute
• 9:00 a.m. – 10:00 a.m. Using Continuous Glucose Monitoring to Advance Cardiometabolic Kidney Care Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP Midwestern University College of Pharmacy Clinical Pharmacist, Northwestern Medicine
• 10:00 a.m. – 10:15 a.m. Break and Exhibit Hall
• 10:15 a.m. – 11:15 a.m. Diabetes Technology Update Kelcey Semple, PharmD, BCACP, BCADM Carle Health
• 11:15 a.m. – 12:15 p.m. Diabetes and Heart Disease Cardiac Rehab and Exercising with Diabetes Kristina Adams-Smith, MS, RD, LDN Joseph Mulconrey, BS
• 12:15 p.m. – 1:00 p.m. Lunch and Exhibit Hall
• 1:00 p.m. – 2:00 p.m. Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Diabetes: Unraveling the Silent Foe Adeyinka Taiwo, MD Endocrinologist Clinical Assistant Professor University of Iowa
• 2:00 p.m. – 3:00 p.m. Insulin Marc Belanger, PharmD Carle Health
• 3:00 p.m. – 3:15 p.m. Break and Exhibit Hall
• 3:15 p.m. – 4:15 p.m. Endocrinology Panel Owaise Mansuri, MD Abbie Morales, RN, BSN, AMB-BC Coral Zahnd, CMA Holly Miller, MBA, RD, LDN, CDCES
• 4:15 p.m. – 4:30 p.m. Closing Remarks Jean Land, MS, RDN, LDN, CDCES Diabetes Program Coordinator Carle Health